slides · global inventory
Disclaimer
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,127
Current window 27,991-28,020
Pages 1,371
Rows per page 30
Component
27,991-28,020 of 41,127
11
The slide outlines the clinical trial structure, including patient eligibility criteria and study objectives for both phases.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
15
The chart displays a log-scale y-axis for concentration. The data supports once-daily (QD) dosing based on a 20h half-life.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
16
Clinical trial data presentation for ENA 2022.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
17
The chart is a classic waterfall plot used in oncology clinical trials to demonstrate drug efficacy.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations 1 hit
18
The chart is a swimmer plot (often used in oncology to show duration of response/treatment).Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations 1 hit
20
The slide uses a before-after-during progression (Baseline, 4 weeks, 8 weeks) to visualize drug efficacy.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations 1 hit
21
The slide uses a timeline-style list on the left to describe the patient's treatment history and a before-after image grid on the right to show clinical response.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations 1 hit
26
The slide uses a combination of scatter plots, bar charts, and a waterfall-style selectivity chart to demonstrate drug efficacy and safety profile.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations 1 hit
28
The slide uses a structured table to define patient eligibility criteria for different cohorts in a clinical trial.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations 1 hit
01
Organicell Regenerative Medicine | Investor Presentation Deck | 17 slidesOrganicell Regenerative Medicine | Investor Presentation Deck | 17 slides · Organicell Regenerative Medicine
Pitch deck Investor relations 1 hit
04
Organicell Regenerative Medicine | Investor Presentation Deck | 17 slidesOrganicell Regenerative Medicine | Investor Presentation Deck | 17 slides · Organicell Regenerative Medicine
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
15
The slide uses a grid layout to categorize patent statuses (Patent Pending vs Provisional Patent) for four distinct product lines.Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides · Organicell Regenerative Medicine
Pitch deck Investor relations 1 hit
02
Overstock | Results Presentation Deck | 34 slidesOverstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations Beat · Attention1 hit
09
Includes footnotes regarding non-GAAP measures and continuing operations.Overstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations Beat · Need1 hit
10
The chart includes a trend line annotation showing a 33% decline from Q3 '21 to Q3 '22.Overstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations Beat · Satisfaction1 hit
11
The chart displays a dual-axis view of gross margin performance over time.Overstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations Beat · Satisfaction1 hit
13
The chart highlights a decline in both absolute EBITDA and margin percentage over the two-year period.Overstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations Beat · Satisfaction1 hit
14
The chart combines a bar chart for active customers and a line chart for order frequency.Overstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations Beat · Satisfaction1 hit
33
Includes a sub-table for 'Special items' and a disclaimer regarding non-GAAP financial measures.Overstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations 1 hit
02
Pathward Financial | Results Presentation Deck | 25 slidesPathward Financial | Results Presentation Deck | 25 slides · Pathward Financial
Conference presentation Investor relations Beat · Attention1 hit
08
Pathward Financial | Results Presentation Deck | 25 slidesPathward Financial | Results Presentation Deck | 25 slides · Pathward Financial
Conference presentation Investor relations Beat · Desire1 hit
18
Includes disclaimer regarding regulatory purpose of data and modeling techniques.Pathward Financial | Results Presentation Deck | 25 slides · Pathward Financial
Conference presentation Investor relations Beat · Action1 hit
23
The table adjusts for the cyclicality of the tax services business line.Pathward Financial | Results Presentation Deck | 25 slides · Pathward Financial
Conference presentation Investor relations Beat · Action1 hit
01
PaxMedica | Investor Presentation Deck | 24 slidesPaxMedica | Investor Presentation Deck | 24 slides · PaxMedica
Pitch deck Investor relations 1 hit
02
PaxMedica | Investor Presentation Deck | 24 slidesPaxMedica | Investor Presentation Deck | 24 slides · PaxMedica
Pitch deck Investor relations 1 hit
07
PaxMedica | Investor Presentation Deck | 24 slidesPaxMedica | Investor Presentation Deck | 24 slides · PaxMedica
Pitch deck Investor relations 1 hit
09
Focuses on the regulatory milestone of an NDA filing and the associated Priority Review Voucher (PRV) opportunity.PaxMedica | Investor Presentation Deck | 24 slides · PaxMedica
Pitch deck Investor relations 1 hit
16
The slide uses a medical/scientific aesthetic with a brain illustration and a healthcare professional.PaxMedica | Investor Presentation Deck | 24 slides · PaxMedica
Pitch deck Investor relations 1 hit
22
The slide uses a human-centric image to emphasize the clinical impact of the drug.PaxMedica | Investor Presentation Deck | 24 slides · PaxMedica
Pitch deck Investor relations 1 hit
24
PaxMedica | Investor Presentation Deck | 24 slidesPaxMedica | Investor Presentation Deck | 24 slides · PaxMedica
Pitch deck Investor relations 1 hit